Results 171 to 180 of about 3,607 (224)
An empirical study of feature extraction for Hubei folk art of carved paper-cutting. [PDF]
Yang Z, Liu Y, Wang W, Li Y, Yuan X.
europepmc +1 more source
Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski +10 more
wiley +1 more source
Between loss and learning: a qualitative interview study of donor family voices and institutional practices in whole-body donation for medical education in Türkiye. [PDF]
Yazar MB +10 more
europepmc +1 more source
Patient‐derived organoids (PDOs) from pancreatic, colorectal, and gastric cancers were used to evaluate standard and experimental therapies. Incorporating cancer‐associated fibroblasts (CAFs) into organoid cultures improved patient therapy outcome prediction.
Marcin Grochowski +12 more
wiley +1 more source
FEBS-IUBMB-ENABLE Conference crosses seven seas: Report on the 3<sup>rd</sup> International Molecular Biosciences PhD and Postdoc Conference-"Artificial intelligence: reshaping biomedical and healthcare research". [PDF]
Ghosh K, Asyiqin D.
europepmc +1 more source
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim +3 more
wiley +1 more source
Learning from animals? shared plant use between Lua herders and water buffalo in Northern Thailand. [PDF]
Lainé N +3 more
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source

